Skip to main content

Thrombotic Risk Assessment

CPT

85300; 85303; 85306; 85307; 85613; 85670; 85732; 86146(x3); 86147(x3); 86148(x2)

Synonyms
  • Antiphospholipid Syndrome Profile

  • Clotting Risk Assessment

  • Hypercoagulability Risk Assessment

  • Thrombosis Risk Assessment

Test Details

Methodology

See individual tests.

Result Turnaround Time

3 - 7 days

Turnaround time is defined as the usual number of days from the date of pickup of a specimen for testing to when the result is released to the ordering provider. In some cases, additional time should be allowed for additional confirmatory or additional reflex tests. Testing schedules may vary.

Related Documents

For more information, please view the literature below.

Test Includes

Thrombophilia Risk, Acquired: Anticardiolipin Antibodies (ACA), IgA, IgG, IgM; Antiphosphatidylserine, IgG and IgM; β2-Glycoprotein 1 Antibodies, IgA, IgG, IgM; Lupus Anticoagulant Reflex; Thrombin Mixing Study

Thrombophilia Risk, Congenital: Activated Protein C Resistance (APCR); Antithrombin (AT) Activity; Protein C, Functional; Protein S, Free

Use

This profile is designed to detect acquired causes of thrombophilia. Refer to individual test descriptions for more information.

Special Instructions

If the patient's hematocrit exceeds 55%, the volume of citrate in the collection tube must be adjusted. Refer to Coagulation Collection Procedures for directions.

Specimen Requirements

Specimen

Sodium citrate plasma, frozen, and serum, refrigerated

Volume

2.6 mL frozen plasma and 2 mL serum

Container

Blue-top (sodium citrate) tube and gel-barrier or red-top tube

Collection Instructions

Citrated plasma samples should be collected by double centrifugation. Blood should be collected in a blue-top tube containing 3.2% buffered sodium citrate.1 Evacuated collection tubes must be filled to completion to ensure a proper blood to anticoagulant ratio.2,3 The sample should be mixed immediately by gentle inversion at least six times to ensure adequate mixing of the anti-coagulant with the blood. A discard tube is not required prior to collection of coagulation samples except when using a winged blood collection device (i.e., "butterfly"), in which case a discard tube should be used.4,5 When non-citrate tubes are collected for other tests, collect sterile and nonadditive (red-top) tubes prior to citrate (blue-top) tubes. Any tube containing an alternate anticoagulant should be collected after the blue-top tube. Gel-barrier tubes and serum tubes with clot initiators should also be collected after the citrate tubes. Centrifuge for 10 minutes and carefully remove 2/3 of the plasma using a plastic transfer pipette, being careful not to disturb the cells. Deliver to a plastic transport tube, cap and recentifuge for 10 minutes. Use a second plastic pipette to remove plasma, staying clear of the platelets at the bottom of the tube. Transfer the plasma into a Labcorp PP transpak frozen purple tube with screw cap (Labcorp No. 49482). Freeze immediately and maintain frozen until tested. To avoid delays in turnaround time when requesting multiple tests on frozen samples, please submit separate frozen specimens for each test requested. It is important to centrifuge blood samples for plasma collection immediately after collection to separate the plasma from the blood cells. If immediate centrifugation is not possible, collected blood specimens should be kept on ice and centrifuged within an hour.

Serum: If a red-top tube is used, transfer separate serum to a plastic transport tube.

Please print and use the Volume Guide for Coagulation Testing to ensure proper draw volume.

Stability Requirements

See individual tests.

Storage Instructions

Freeze plasma; refrigerate serum.

Patient Preparation

Do not draw from an arm with a heparin lock or heparinized catheter.

Causes for Rejection

Gross hemolysis; clotted specimen; frozen specimen thawed in transit; improper labeling

Footnotes

1. Adcock DM, Kressin DC, Marlar RA. Effect of 3.2% vs 3.8% sodium citrate concentration on routine coagulation testing. Am J Clin Pathol. 1997 Jan;107(1):105-110. PubMed 8980376

2. Reneke J, Etzell J, Leslie S, Ng VL, Gottfried EL. Prolonged pro-thrombin time and activated partial thromboplastin time due to underfilled specimen tubes with 109 mmol/L (3.2%) citrate anticoagulant. Am J Clin Pathol. 1998 Jun;109(6):754-757. PubMed 9620035

3. National Committee for Clinical Laboratory Standardization. Collection, Transport, and Processing of Blood Specimens for Coagulation Testing and General Performance of Coagulation Assays; Approved Guideline. 5th ed., Villanova, PA: NCCLS; 2008. Document H21-A5:28(5).

4. Gottfried EL, Adachi MM. Prothrombin time and activated partial thromboplastin time can be performed on the first tube. Am J Clin Pathol. 1997 Jun;107(6):681-683. PubMed 9169665

5. McGlasson DL, More L, Best HA, Norris WL, Doe RH, Ray H. Drawing specimens for coagulation testing: Is a second tube necessary? Clin Lab Sci. 1999 May-Jun;12(3):137-139. PubMed 10539100

LOINC® Map

Order Code Order Code Name Order Loinc Result Code Result Code Name UofM Result LOINC
117155 Thrombotic Risk Assessment 117003 PTT-LA sec 34571-0
117155 Thrombotic Risk Assessment 117891 dRVVT sec 6303-2
117155 Thrombotic Risk Assessment 117893 Lupus Reflex Interpretation 75514-0
117155 Thrombotic Risk Assessment 109009 Thrombin Time sec 3243-3
117155 Thrombotic Risk Assessment 161812 Anticardiolipin Ab,IgG,Qn GPL U/mL 3181-5
117155 Thrombotic Risk Assessment 161830 Anticardiolipin Ab,IgM,Qn MPL U/mL 3182-3
117155 Thrombotic Risk Assessment 161838 Anticardiolipin Ab,IgA,Qn APL U/mL 5076-5
117155 Thrombotic Risk Assessment 163881 Beta-2 Glycoprotein I Ab, IgG GPI IgG units 16135-6
117155 Thrombotic Risk Assessment 163899 Beta-2 Glycoprotein I Ab, IgA GPI IgA units 21108-6
117155 Thrombotic Risk Assessment 163907 Beta-2 Glycoprotein I Ab, IgM GPI IgM units 16136-4
117155 Thrombotic Risk Assessment 117927 Antiphosphatidylserine IgG Units 14245-5
117155 Thrombotic Risk Assessment 117910 Antiphosphatidylserine IgM Units 14246-3
117155 Thrombotic Risk Assessment 117763 Act.Prt.C Resist. ratio 13590-5
117155 Thrombotic Risk Assessment 015040 Antithrombin Activity % 27811-9
117155 Thrombotic Risk Assessment 117705 Protein C-Functional % 27818-4
117155 Thrombotic Risk Assessment 164519 Protein S, Free % 27821-8
Order Code117155
Order Code NameThrombotic Risk Assessment
Order Loinc
Result Code117003
Result Code NamePTT-LA
UofMsec
Result LOINC34571-0
Order Code117155
Order Code NameThrombotic Risk Assessment
Order Loinc
Result Code117891
Result Code NamedRVVT
UofMsec
Result LOINC6303-2
Order Code117155
Order Code NameThrombotic Risk Assessment
Order Loinc
Result Code117893
Result Code NameLupus Reflex Interpretation
UofM
Result LOINC75514-0
Order Code117155
Order Code NameThrombotic Risk Assessment
Order Loinc
Result Code109009
Result Code NameThrombin Time
UofMsec
Result LOINC3243-3
Order Code117155
Order Code NameThrombotic Risk Assessment
Order Loinc
Result Code161812
Result Code NameAnticardiolipin Ab,IgG,Qn
UofMGPL U/mL
Result LOINC3181-5
Order Code117155
Order Code NameThrombotic Risk Assessment
Order Loinc
Result Code161830
Result Code NameAnticardiolipin Ab,IgM,Qn
UofMMPL U/mL
Result LOINC3182-3
Order Code117155
Order Code NameThrombotic Risk Assessment
Order Loinc
Result Code161838
Result Code NameAnticardiolipin Ab,IgA,Qn
UofMAPL U/mL
Result LOINC5076-5
Order Code117155
Order Code NameThrombotic Risk Assessment
Order Loinc
Result Code163881
Result Code NameBeta-2 Glycoprotein I Ab, IgG
UofMGPI IgG units
Result LOINC16135-6
Order Code117155
Order Code NameThrombotic Risk Assessment
Order Loinc
Result Code163899
Result Code NameBeta-2 Glycoprotein I Ab, IgA
UofMGPI IgA units
Result LOINC21108-6
Order Code117155
Order Code NameThrombotic Risk Assessment
Order Loinc
Result Code163907
Result Code NameBeta-2 Glycoprotein I Ab, IgM
UofMGPI IgM units
Result LOINC16136-4
Order Code117155
Order Code NameThrombotic Risk Assessment
Order Loinc
Result Code117927
Result Code NameAntiphosphatidylserine IgG
UofMUnits
Result LOINC14245-5
Order Code117155
Order Code NameThrombotic Risk Assessment
Order Loinc
Result Code117910
Result Code NameAntiphosphatidylserine IgM
UofMUnits
Result LOINC14246-3
Order Code117155
Order Code NameThrombotic Risk Assessment
Order Loinc
Result Code117763
Result Code NameAct.Prt.C Resist.
UofMratio
Result LOINC13590-5
Order Code117155
Order Code NameThrombotic Risk Assessment
Order Loinc
Result Code015040
Result Code NameAntithrombin Activity
UofM%
Result LOINC27811-9
Order Code117155
Order Code NameThrombotic Risk Assessment
Order Loinc
Result Code117705
Result Code NameProtein C-Functional
UofM%
Result LOINC27818-4
Order Code117155
Order Code NameThrombotic Risk Assessment
Order Loinc
Result Code164519
Result Code NameProtein S, Free
UofM%
Result LOINC27821-8
Reflex Table for PTT-LA
Order Code Order Name Result Code Result Name UofM Result LOINC
Reflex 1 117040 PTT-LA Mix 117005 PTT-LA Mix sec 75510-8
Reflex 2 117020 Hexagonal Phase Phospholipid 117842 Hexagonal Phase Phospholipid sec 3282-1
Reflex 1
Order Code117040
Order NamePTT-LA Mix
Result Code117005
Result NamePTT-LA Mix
UofMsec
Result LOINC75510-8
Reflex 2
Order Code117020
Order NameHexagonal Phase Phospholipid
Result Code117842
Result NameHexagonal Phase Phospholipid
UofMsec
Result LOINC3282-1
Reflex Table for Thrombin Time
Order Code Order Name Result Code Result Name UofM Result LOINC
Reflex 1 117110 TT Mix+TTN 117171 Thrombin Time Mix sec 33525-7
Reflex 1
Order Code117110
Order NameTT Mix+TTN
Result Code117171
Result NameThrombin Time Mix
UofMsec
Result LOINC33525-7
Reflex Table for Thrombin Time
Order Code Order Name Result Code Result Name UofM Result LOINC
Reflex 1 117110 TT Mix+TTN 117203 Thrombin Neutralization sec 46224-2
Reflex 1
Order Code117110
Order NameTT Mix+TTN
Result Code117203
Result NameThrombin Neutralization
UofMsec
Result LOINC46224-2